Prenatal IL-6 levels and activation of the tryptophan to kynurenine pathway are associated with depressive but not anxiety symptoms across the perinatal and the post-partum period in a low-risk sample.

Brain, Behavior, and Immunity
S NazzariA Frigerio

Abstract

Depression and anxiety symptoms are highly prevalent among women during pregnancy and post-partum. Previous studies suggest that one of the pathophysiological underpinnings could be an enhanced metabolism of tryptophan (Trp) into kynurenine (Kyn) due to increased inflammation. However, the longitudinal changes in the Kyn pathway and the complex interplay with inflammation and stress in women with perinatal depressive or anxiety symptoms are incompletely understood. We examined a cohort of healthy women at 34-36 gestational weeks. One hundred and ten women were assessed for salivary cortisol and 97 participants were also assessed for serum levels of Trp, Kyn and Interleukin 6 (IL-6). Women filled in two screening questionnaires for depressive (Edinburgh Postnatal Depression Scale (EPDS)) and anxiety (State Trait Anxiety Inventory subscale (STAI-S)) symptoms at 34-36 gestational weeks, delivery, 3 and 12 months postpartum. Unexpectedly, lower prenatal Kyn levels were associated with higher depressive symptoms in late pregnancy. Furthermore, prenatal Trp levels and the Kyn/Trp ratio moderate the association between IL-6 levels and depressive symptoms during the perinatal and the post-partum period. We found no interactions between...Continue Reading

References

Jun 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·J L CoxR Sagovsky
May 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·P R GardG Waldron
Jun 9, 1999·Journal of Affective Disorders·P BenvenutiJ L Cox
Aug 4, 2001·BMJ : British Medical Journal·J EvansJ Golding
Dec 14, 2002·Life Sciences·Katharina SchröcksnadelDietmar Fuchs
Apr 20, 2004·Journal of Affective Disorders·Jonathan HeronUNKNOWN ALSPAC Study Team
Apr 28, 2005·Psychoneuroendocrinology·Daniel J HruschkaCarol M Worthman
Jun 7, 2005·Journal of Affective Disorders·Claudia KohlBarbara Sperner-Unterweger
Jun 23, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Stefano ComaiGraziella Allegri
Nov 24, 2005·Psychoneuroendocrinology·K M' BaïlaraJ Demotes-Mainard
Sep 6, 2006·Journal of Affective Disorders·Aye-Mu MyintBrian Leonard
Dec 7, 2006·JAMA : the Journal of the American Medical Association·Trine Munk-OlsenPreben Bo Mortensen
Dec 26, 2006·Archives of Women's Mental Health·A Faisal-Cury, P Rossi Menezes
Nov 6, 2007·Obstetrics and Gynecology·Antoinette M LeeDaniel Yee Tak Fong
Feb 4, 2009·Psychosomatic Medicine·M Bryant HowrenJerry Suls
Dec 18, 2009·Biological Psychiatry·Yekta DowlatiKrista L Lanctôt
Sep 22, 2010·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Elysia Poggi DavisCurt A Sandman
Nov 17, 2010·Journal of Affective Disorders·Rose Meades, Susan Ayers
Oct 18, 2011·Psychoneuroendocrinology·Kieran J O'DonnellVivette Glover
Jan 1, 2009·International Journal of Tryptophan Research : IJTR·Yiquan Chen, Gilles J Guillemin
Nov 25, 2011·Journal of Alzheimer's Disease : JAD·Nikoletta DobosUlrich L M Eisel
Jun 9, 2012·Nature Reviews. Neuroscience·Robert SchwarczHui-Qiu Wu
Mar 21, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Adam K WalkerRobert Dantzer
Apr 2, 2013·Psychoneuroendocrinology·Elizabeth J CorwinBrian Stafford
Apr 24, 2013·Psychoneuroendocrinology·Lauren M Osborne, Catherine Monk
Nov 5, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Aye-Mu Myint, Yong-Ku Kim
Jul 1, 2014·American Journal of Reproductive Immunology : AJRI·Yoko UrataYutaka Osuga
Aug 12, 2014·Obstetrics & Gynecology Science·Abdulla A-B Badawy
Sep 19, 2014·Biological Research for Nursing·Melissa M SheltonMaureen W Groer
Oct 9, 2014·The Journal of Clinical Psychiatry·Shintaro OgawaHiroshi Kunugi
May 6, 2015·Brain, Behavior, and Immunity·Elizabeth J CorwinDonna O McCarthy
Mar 27, 2016·Journal of Affective Disorders·Kobra Falah-HassaniCindy-Lee Dennis
Oct 22, 2016·Journal of Psychiatry & Neuroscience : JPN·Sarah M ClarkLeonardo H Tonelli
Apr 28, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Stefano ComaiGabriella Gobbi

❮ Previous
Next ❯

Citations

Dec 11, 2020·JCI Insight·James M KeaneSiobhain M O'Mahony

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.